Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-2094
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson’s disease ; volume:15 ; number:1 ; day:30 ; month:8 ; year:2018 ; pages:1-14 ; date:12.2018
Journal of neuroinflammation ; 15, Heft 1 (30.8.2018), 1-14, 12.2018
- Creator
-
Williams, Gregory P.
- Contributor
-
Schonhoff, Aubrey M.
Jurkuvenaite, Asta
Thome, Aaron D.
Standaert, David G.
Harms, Ashley
SpringerLink (Online service)
- DOI
-
10.1186/s12974-018-1286-2
- URN
-
urn:nbn:de:101:1-2018102100383279787863
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:39 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Williams, Gregory P.
- Schonhoff, Aubrey M.
- Jurkuvenaite, Asta
- Thome, Aaron D.
- Standaert, David G.
- Harms, Ashley
- SpringerLink (Online service)
Other Objects (12)
Microglial inhibition alleviates alpha-synuclein propagation and neurodegeneration in Parkinson’s disease mouse model
Transmission of alpha-synuclein in Parkinson’s disease
Transmission von Alpha-Synuclein beim Morbus Parkinson
Mitochondrial dynamics in alpha-synuclein model of Parkinson`s disease
Alpha-synuclein in Parkinson’s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction
Cell-to-cell transmitted alpha-synuclein recapitulates experimental Parkinson’s disease
Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease
Alpha-synuclein structure and Parkinson’s disease – lessons and emerging principles
The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease
Nanoplastic Stimulates the Amyloidogenesis of Parkinson's Alpha‐Synuclein NACore
Endonuclease G mediates [alpha]-synuclein cytotoxicity during Parkinson's disease
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
Microglial inhibition alleviates alpha-synuclein propagation and neurodegeneration in Parkinson’s disease mouse model
Transmission of alpha-synuclein in Parkinson’s disease
Transmission von Alpha-Synuclein beim Morbus Parkinson
Mitochondrial dynamics in alpha-synuclein model of Parkinson`s disease
Alpha-synuclein in Parkinson’s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction
Cell-to-cell transmitted alpha-synuclein recapitulates experimental Parkinson’s disease
Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease
Alpha-synuclein structure and Parkinson’s disease – lessons and emerging principles
The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease
Nanoplastic Stimulates the Amyloidogenesis of Parkinson's Alpha‐Synuclein NACore
Endonuclease G mediates [alpha]-synuclein cytotoxicity during Parkinson's disease
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
Microglial inhibition alleviates alpha-synuclein propagation and neurodegeneration in Parkinson’s disease mouse model
Transmission of alpha-synuclein in Parkinson’s disease
Transmission von Alpha-Synuclein beim Morbus Parkinson
Mitochondrial dynamics in alpha-synuclein model of Parkinson`s disease
Alpha-synuclein in Parkinson’s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction
Cell-to-cell transmitted alpha-synuclein recapitulates experimental Parkinson’s disease
Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease
Alpha-synuclein structure and Parkinson’s disease – lessons and emerging principles
The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease
Nanoplastic Stimulates the Amyloidogenesis of Parkinson's Alpha‐Synuclein NACore
Endonuclease G mediates [alpha]-synuclein cytotoxicity during Parkinson's disease